Catalyst Wire Dossier Catalyst Wire Dossier

Atropine sulfate eye drops (0.01%/0.02%)

atropine sulfate eye drops · Oupushifang Pharmaceutical Technology Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Atropine sulfate eye drops (0.01%/0.02%), covering 2024-12-24 to 2024-12-24. Get the full timeline:

Most recent: Clinical Trial Update: The Effectiveness and Safety of Two Low-concentration Atropine Sulfate Eye Drops (0.01%/0.02%) for Delaying the Pediatric Myopia Progression [Phase 3]

See pricing